Unichem profits climb 49%: Acquisitions boost figures as sales cross pounds 1bn mark for first time
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.UNICHEM, the pharmaceutical wholesaler and retailer, lifted taxable profits by 49 per cent in 1992 after group sales crossed the pounds 1bn mark for the first time.
Pre-tax profits, helped by acquisitions, rose from pounds 21.4m to pounds 31.9m for the 12 months to 31 December.
Jeff Harris, chief executive, said about half the increase in profits was due to acquisitions, and half derived from organic growth. Unichem bought three drug wholesalers in Portugal early last year. It has also been building a chain of high street chemists, adding 79 outlets to make 209 at the year end. All trade under the Moss banner.
Overall operating profit margins improved from 2.4 per cent to 3.3 per cent, a reflection of the much healthier margins in retailing where Unichem is a relative newcomer.
Unichem took a pounds 2.5m extraordinary charge - soon to be outlawed under new accounting standards - in relation to the closure of its Neptune nappy business. In 1991 the company had a pounds 1m extraordinary charge for an unsuccessful takeover attempt.
The shares rose from 236p to 243.5p yesterday. The shares have outpaced the stock market average by 50 per cent since Unichem was floated in 1990.
Earnings per share, calculated before the extraordinary items, were 15.1p against 13.3p. The dividend is 5.75p (5p).
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments